Correlation Between Heron Therapeuti and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Heron Therapeuti and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heron Therapeuti and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Heron Therapeuti and Mereo BioPharma Group, you can compare the effects of market volatilities on Heron Therapeuti and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heron Therapeuti with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heron Therapeuti and Mereo BioPharma.
Diversification Opportunities for Heron Therapeuti and Mereo BioPharma
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Heron and Mereo is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Heron Therapeuti and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Heron Therapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heron Therapeuti are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Heron Therapeuti i.e., Heron Therapeuti and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Heron Therapeuti and Mereo BioPharma
Given the investment horizon of 90 days Heron Therapeuti is expected to generate 1.89 times more return on investment than Mereo BioPharma. However, Heron Therapeuti is 1.89 times more volatile than Mereo BioPharma Group. It trades about 0.19 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.16 per unit of risk. If you would invest 122.00 in Heron Therapeuti on December 2, 2024 and sell it today you would earn a total of 125.00 from holding Heron Therapeuti or generate 102.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Heron Therapeuti vs. Mereo BioPharma Group
Performance |
Timeline |
Heron Therapeuti |
Mereo BioPharma Group |
Heron Therapeuti and Mereo BioPharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Heron Therapeuti and Mereo BioPharma
The main advantage of trading using opposite Heron Therapeuti and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heron Therapeuti position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.Heron Therapeuti vs. Mereo BioPharma Group | Heron Therapeuti vs. Terns Pharmaceuticals | Heron Therapeuti vs. PDS Biotechnology Corp | Heron Therapeuti vs. Inozyme Pharma |
Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |